Zogenix Announces Conference Call and Webcast to Present Second Quarter 2014
Conference Call Scheduled for August 5, 2014 at 4:30 pm ET
SAN DIEGO, July 22, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a
pharmaceutical company developing and commercializing products for the
treatment of pain-related and central nervous system (CNS) disorders, today
announced it will release financial results for the second quarter ended June
30, 2014, after the market closes on Tuesday, August 5, 2014, and will hold a
conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these
financial results and provide a company update.
To access the live webcast please visit the Company's Investor Relations
website at ir.zogenix.com, and to participate, please dial 877-417-5253 (U.S.)
or 315-625-3082 (International); participant passcode: 76176599.
The conference call will be hosted by Chief Executive Officer Roger L. Hawley,
President Stephen J. Farr, Ph.D., and Executive Vice President and Chief
Financial Officer Ann Rhoads.
A replay of the conference call will be available beginning August 5, 2014 at
7:30 p.m. ET (4:30 p.m. PT) until August 12, 2014, by dialing 855-859-2056
(U.S.) or 404-537-3406 (International); passcode: 76176599. A replay of the
webcast will also be accessible on the Investor Relations website for one
month, through September 5, 2014.
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to
developing and commercializing therapies that address specific clinical needs
for people living with pain-related conditions and CNS disorders who need
innovative treatment alternatives to help them return to normal daily
Zack Kubow, The Ruth Group
Aaron Estrada, The Ruth Group
Press spacebar to pause and continue. Press esc to stop.